The leading US drug regulator “is establishing monopolies” by denying approval to drugs, says Bob Essner, outgoing chief executive of Wyeth.

Mr Essner said the Food and Drug Administration was blocking new drugs after their efficacy was compared to those already on the market. He said this was beyond its mandate and could prompt legal action.